camptothecin has been researched along with thioctic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Gao, D; Ibrahim, S; Sinko, PJ | 1 |
Du, Y; He, W; Ismail, M; Li, X; Ling, L; Xia, Q; Yao, C | 1 |
Du, Y; He, W; Li, M; Li, X; Wang, T; Zhou, W | 1 |
3 other study(ies) available for camptothecin and thioctic acid
Article | Year |
---|---|
Selective cytotoxicity and combined effects of camptothecin or paclitaxel with sodium-R-alpha lipoate on A549 human non-small cell lung cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Epithelial Cells; Humans; Lung Neoplasms; Paclitaxel; Thioctic Acid; Tumor Cells, Cultured | 2014 |
High Drug Loading, Reversible Disulfide Core-Cross-Linked Multifunctional Micelles for Triggered Release of Camptothecin.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cross-Linking Reagents; Drug Carriers; Drug Compounding; Drug Liberation; Drug Screening Assays, Antitumor; Drug Stability; Glutathione; Hep G2 Cells; Humans; MCF-7 Cells; Micelles; Nanoparticles; Neoplasms; Particle Size; Polyethylene Glycols; Thioctic Acid | 2018 |
Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Survival; Drug Carriers; Drug Liberation; Erythrocytes; Hemolysis; Hep G2 Cells; Humans; MCF-7 Cells; Micelles; Nanoparticles; Polyethylene Glycols; Prodrugs; Propanolamines; Propylene Glycols; Surface-Active Agents; Thioctic Acid | 2020 |